loading

Xenon Pharmaceuticals Inc Aktie (XENE) Neueste Nachrichten

pulisher
03:28 AM

Xenon Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:XENE) - Defense World

03:28 AM
pulisher
May 27, 2025

Ameriprise Financial Inc. Increases Position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

May 27, 2025
pulisher
May 26, 2025

(XENE) Investment Analysis and Advice - news.stocktradersdaily.com

May 26, 2025
pulisher
May 25, 2025

Northern Trust Corp Raises Stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

May 25, 2025
pulisher
May 23, 2025

Xenon Pharmaceuticals (NASDAQ:XENE) Rating Lowered to “Sell” at Wall Street Zen - Defense World

May 23, 2025
pulisher
May 21, 2025

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

May 21, 2025
pulisher
May 20, 2025

Xenon Pharmaceuticals’ SWOT analysis: neurological drug stock faces pivotal year - Investing.com India

May 20, 2025
pulisher
May 18, 2025

Analysts Issue Forecasts for XENE FY2025 Earnings - Defense World

May 18, 2025
pulisher
May 17, 2025

Leerink Partnrs Has Bullish Forecast for XENE Q2 Earnings - Defense World

May 17, 2025
pulisher
May 16, 2025

XENE FY2025 EPS Estimate Decreased by Cantor Fitzgerald - Defense World

May 16, 2025
pulisher
May 16, 2025

What is William Blair’s Estimate for XENE FY2025 Earnings? - Defense World

May 16, 2025
pulisher
May 16, 2025

Xenon Pharmaceuticals (NASDAQ:XENE) Coverage Initiated at Evercore ISI - Defense World

May 16, 2025
pulisher
May 16, 2025

HC Wainwright Issues Optimistic Outlook for XENE Earnings - Defense World

May 16, 2025
pulisher
May 15, 2025

How To Trade (XENE) - news.stocktradersdaily.com

May 15, 2025
pulisher
May 15, 2025

Traders Buy High Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE) - Defense World

May 15, 2025
pulisher
May 15, 2025

Chardan Capital Reiterates “Buy” Rating for Xenon Pharmaceuticals (NASDAQ:XENE) - Defense World

May 15, 2025
pulisher
May 15, 2025

Xenon Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:XENE) - Defense World

May 15, 2025
pulisher
May 15, 2025

Xenon Q1 Loss Narrower Than Expected, Pipeline Development in Focus - MSN

May 15, 2025
pulisher
May 15, 2025

Needham & Company LLC Lowers Xenon Pharmaceuticals (NASDAQ:XENE) Price Target to $55.00 - Defense World

May 15, 2025
pulisher
May 15, 2025

Wells Fargo & Company Has Lowered Expectations for Xenon Pharmaceuticals (NASDAQ:XENE) Stock Price - Defense World

May 15, 2025
pulisher
May 15, 2025

Xenon Pharmaceuticals (NASDAQ:XENE) Stock Rating Upgraded by StockNews.com - Defense World

May 15, 2025
pulisher
May 14, 2025

Evercore ISI Group Initiates Coverage of Xenon Pharmaceuticals (XENE) with Outperform Recommendation - Nasdaq

May 14, 2025
pulisher
May 14, 2025

Xenon signals Phase 3 epilepsy readout in early 2026 with expanded pipeline advancements - MSN

May 14, 2025
pulisher
May 14, 2025

Xenon Pharmaceuticals to Present at 2025 RBC Healthcare Conference - TipRanks

May 14, 2025
pulisher
May 14, 2025

Xenon to Present at the 2025 RBC Capital Markets Global Healthcare Conference - The Manila Times

May 14, 2025
pulisher
May 14, 2025

Xenon CEO to Showcase Revolutionary Late-Stage Epilepsy Treatment: Key Updates Coming at RBC Conference - Stock Titan

May 14, 2025
pulisher
May 14, 2025

XENE: Evercore ISI Group Initiates Coverage with 'Outperform' Ra - GuruFocus

May 14, 2025
pulisher
May 14, 2025

XENE: Evercore ISI Group Initiates Coverage with 'Outperform' Rating | XENE Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Why Xenon Pharmaceuticals Inc. (XENE) Declined on Tuesday - Insider Monkey

May 14, 2025
pulisher
May 14, 2025

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q1 2025 Earnings Call Transcript - Insider Monkey

May 14, 2025
pulisher
May 14, 2025

XENE: Wells Fargo Adjusts Price Target for Xenon Pharmaceuticals - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Xenon Pharmaceuticals (XENE) Price Target Adjusted by Analyst | - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Xenon Pharmaceuticals (NASDAQ:XENE) Shares Gap Down After Analyst Downgrade - Defense World

May 14, 2025
pulisher
May 14, 2025

XENE: HC Wainwright Reiterates Buy Rating for Xenon Pharmaceuticals | XENE Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

XENE: RBC Capital Adjusts Price Target as Xenon Pharmaceuticals Faces Timeline Shift | XENE Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

XENE: Analyst Reaffirms Buy Rating with Price Target of $55 | XE - GuruFocus

May 14, 2025
pulisher
May 14, 2025

XENE Price Target Revised Following Earnings and Data Delay | XE - GuruFocus

May 14, 2025
pulisher
May 14, 2025

XENE: Needham Adjusts Price Target on Xenon Pharmaceuticals | XE - GuruFocus

May 14, 2025
pulisher
May 13, 2025

XENE: RBC Capital Lowers Xenon Pharmaceuticals Price Target | XE - GuruFocus

May 13, 2025
pulisher
May 13, 2025

FOS-tering patience: Xenon moves azetukalner data to next year - BioWorld MedTech

May 13, 2025
pulisher
May 13, 2025

Xenon Pharmaceuticals stock falls on delayed study results By Investing.com - Investing.com Nigeria

May 13, 2025
pulisher
May 13, 2025

Xenon Pharmaceuticals stock falls on delayed study results - Investing.com Australia

May 13, 2025
pulisher
May 13, 2025

Xenon Pharmaceuticals Inc (XENE) Q1 2025 Earnings Call Highlights: Strong Financial Position ... - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

Xenon Pharmaceuticals Inc (XENE) Q1 2025 Earnings Call Highlight - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Xenon Pharmaceuticals Inc (XENE) Q1 2025 Earnings Call Highlights: Strong Financial Position and Promising Clinical Developments - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Xenon Pharmaceuticals Advances Clinical Programs Amid Financial Loss - TipRanks

May 13, 2025
pulisher
May 12, 2025

Xenon Pharmaceuticals Reports Q1 2025 Results and Advances Clinical Pipeline - TipRanks

May 12, 2025
pulisher
May 12, 2025

XENE: Xenon Advances Phase 3 Programs in Epilepsy and Psychiatry | XENE Stock News - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Xenon Pharmaceuticals Inc (XENE) Q1 2025 Earnings: EPS Loss of $0.83 Beats Estimate, Revenue Soars to $7.5 Million - GuruFocus

May 12, 2025
pulisher
May 12, 2025

XENON PHARMACEUTICALS Earnings Results: $XENE Reports Quarterly Earnings - Nasdaq

May 12, 2025
pulisher
May 12, 2025

Xenon Pharmaceuticals: Q1 Earnings Snapshot - San Antonio Express-News

May 12, 2025
pulisher
May 12, 2025

Xenon Pharmaceuticals Q1 Loss Widens; Shares Drop - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

Xenon Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times

May 12, 2025
$1.05
price down icon 8.70%
$30.28
price down icon 2.39%
$576.24
price down icon 0.61%
$287.50
price down icon 1.35%
$4.35
price up icon 1.64%
$73.93
price down icon 2.22%
Kapitalisierung:     |  Volumen (24h):